Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating givinostat in ambulant Duchenne muscular dystrophy completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• Givinostat (givinostat)

Snippet

Sponsor: Italfarmaco | Conditions: Duchenne Muscular Dystrophy | Phase 3 | Status: COMPLETED | Results posted: 2023-02-02